Skip to content

Tango Therapeutics

US · TNGX #2322 by market cap Listed 1970
21.73 -0.98 -4.32%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:41

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 11 in the most recent period (2026/Q3).
  • Total institutional ownership rose 8.6 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
136.60% +8.57pp
Institutions
307 +11
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund58.82%
Hedge Fund50.96%
VC/PE Fund18.75%
Public Company7.21%
Individual/Insider1.06%
Private Company0.30%
Insurance Company0.26%
Government Pension Fund0.23%

Top holders as of 2026-10-30

FMR 14.92% · 25.29M sh
RTW Investments, LP 8.20% · 13.90M sh
BlackRock 7.76% · 13.14M sh
Farallon Capital Management, L.L.C. 7.24% · 12.28M sh
Boxer Capital Management, LLC 6.42% · 10.88M sh
The Goldman Sachs Group, Inc. 5.69% · 9.65M sh
TCG Crossover Management, LLC 5.36% · 9.08M sh
State Street Global Advisors 4.32% · 7.32M sh
Vanguard Capital Management, LLC 4.08% · 6.87M sh
Artal Group S.A. 4.00% · 6.78M sh
Third Rock Ventures, LLC 3.90% · 6.57M sh
T. Rowe Price Group, Inc. 3.90% · 6.60M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 25 buys · 22 sells

NameRoleStake
Barbara Weber Officer 0.92%
Daniella Beckman Former Chief Financial Officer 0.08%
Mace Rothenberg Independent Director 0.02%
John Ketchum Independent Director 0.01%
Adam Crystal President of Research & Development 0.01%
Lesley Calhoun Independent Director 0.01%
Malte Peters Chief Executive Officer 0.01%
Alexis Borisy Former Lead Independent Director 0.01%
Jessica Newcomb -- 0.00%
Third Rock Ventures, LLC -- --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-01 Jessica Newcomb -- Automatic Disposition -7,031 $22.28–22.98
2026-11-01 Adam Crystal President of Research & Development Derivative Exercise and Sale -5,000 $2.91–22.99
2026-09-30 Adam Crystal President of Research & Development Derivative Exercise and Sale -27,000 $5.20–25.32
2026-09-21 Jessica Newcomb -- Automatic Disposition -8,200 $22.80–25.17
2026-08-31 Adam Crystal President of Research & Development Derivative Exercise and Sale -27,000 $5.20–22.37
2026-08-02 Adam Crystal President of Research & Development Derivative Exercise and Sale -27,000 $5.20–27.35
2026-06-30 Adam Crystal President of Research & Development Derivative Exercise and Sale -27,000 $5.20–30.25
2026-06-18 Robert Azelby Independent Chairperson Other Acquisition +5,740 --
2026-06-18 Robert Azelby Independent Chairperson Other Derivative Acquisition +35,910 $27.97
2026-06-16 Nextech Invest Ltd. -- Intent to Sell (Form 144) -3,766,081 $30.10
2026-06-10 Daniella Beckman Former Chief Financial Officer Intent to Sell (Form 144) -1,791,726 $28.76
2026-06-09 Daniella Beckman Former Chief Financial Officer Intent to Sell (Form 144) -4,446 $30.00
2026-06-04 Mace Rothenberg Independent Director Other Acquisition +4,000 --
2026-06-04 Mace Rothenberg Independent Director Other Derivative Acquisition +25,000 $20.22
2026-06-04 Lesley Calhoun Independent Director Other Acquisition +4,000 --
2026-06-04 Lesley Calhoun Independent Director Other Derivative Acquisition +25,000 $20.22
2026-06-04 John Ketchum Independent Director Other Acquisition +4,000 --
2026-06-04 John Ketchum Independent Director Other Derivative Acquisition +25,000 $20.22
2026-06-04 Sung Lee Lead Independent Director Other Acquisition +570 --
2026-06-04 Sung Lee Lead Independent Director Other Derivative Acquisition +3,570 $20.22

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:41:45 · For reference only, not investment advice and not tailored to your situation.

Tango Therapeutics discussion 0 comments

Add a comment